文献速递肝胆胰外科围术期管理与 ERAS

机器人联合ERAS路径优化胰十二指肠切除术结局与费用

A Combination of Robotic Approach and ERAS Pathway Optimizes Outcomes and Cost for Pancreatoduodenectomy.
PubMed 文献 · Ann Surg · 2019-01-01

该回顾性研究分析254例连续胰十二指肠切除术(机器人62%,开腹38%),比较ERAS实施前后及两种术式对住院时间和总费用的影响。结果显示ERAS患者住院时间更短(6 vs 8天,P=0.004)且总费用更低(20362 vs 24277美元,P=0.001),机器人手术与更短住院时间相关(7 vs 8天,P=0.0001)而费用相似。多变量分析中,ERAS联合机器人路径较其他组合协同降低住院时间和总费用。

要点

  • ERAS路径独立降低胰十二指肠切除术的总费用。
  • 机器人胰十二指肠切除术与更短住院时间相关。
  • ERAS联合机器人路径协同优化住院时间和费用。

核心结论

  • ERAS实施独立降低胰十二指肠切除术的费用。
  • ERAS联合机器人路径较其他策略协同降低住院时间和总费用。

研究设计与样本

  • 回顾性综述2014年7月至2016年7月连续胰十二指肠切除术病例,分ERAS前和ERAS期。
  • 共分析254例,机器人62%,开腹38%,中位年龄67岁,女性47%。

主要发现

  • ERAS患者住院时间6天 vs 非ERAS 8天(P=0.004),总费用20362 vs 24277美元(P=0.001)。
  • 机器人手术住院时间7天 vs 开腹8天(P=0.0001),费用相似。

临床怎么用

  • 胰十二指肠切除术中实施ERAS路径以降低费用。
  • 优先选择ERAS联合机器人路径以协同缩短住院时间和优化费用。

局限性

  • 回顾性研究设计可能引入选择偏倚。
  • 单中心数据,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the impact of enhanced recovery after surgery (ERAS) pathway implementation on outcomes, and cost of robotic and open pancreatoduodenectomy. BACKGROUND: ERAS pathways have shown benefit in open pancreatoduodenectomy (OPD). The impact of ERAS on robotic pancreatoduodenectomy (RPD) is unknown. METHODS: Retrospective review of consecutive RPD and OPDs in the pre-ERAS (July, 2014-July, 2015) and ERAS (July, 2015-July, 2016) period. Univariate and multivariate logistic regression was used to determine impact of ERAS and operative approach alone, or in combination (pre-ERAS + OPD, pre-ERAS + RPD, ERAS + OPD, ERAS + RPD) on length of hospital stay (LOS) and overall cost. RESULTS: In all, 254 consecutive pancreatoduodenectomies (RPD 62%, OPD 38%) were analyzed (median age 67, 47% female). ERAS patients had shorter LOS (6 vs 8 days; P = 0.004) and decreased overall cost (USD 20,362 vs 24,277; P = 0.001) compared with non-ERAS patients, whereas RPD was associated with decreased LOS (7 vs 8 days; P = 0.0001) and similar cost compared with OPD. On multivariable analysis (MVA), RPD was predictive of shorter LOS [odds ratio (OR) 0.33, confidence interval (CI) 0.16-0.67, P = 0.002), whereas ERAS was protective against high cost (OR 0.57, CI 0.33-0.97, P = 0.037). On MVA, when combining operative approach with ERAS pathway use, a combined ERAS + RPD approach was associated with reduced LOS and optimal cost compared with other combinations (pre-ERAS + OPD, pre-ERAS + RPD, ERAS + OPD). CONCLUSION: ERAS implementation is independently associated with cost savings for pancreatoduodenectomy. A combination of ERAS and robotic approach synergistically decreases hospital stay and overall cost compared with other strategies.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Kowalsky SJ, Zenati MS, Steve J, et al. A Combination of Robotic Approach and ERAS Pathway Optimizes Outcomes and Cost for Pancreatoduodenectomy. Ann Surg. 2019. PMID: 31082913. doi:10.1097/SLA.0000000000002707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。